Silent cerebral embolism
1 paper
- Human trial1
Trial sponsors
1 trialPhase 4150 people
The First Affiliated Hospital with Nanjing Medical University
1 trialPhase 4150 people
Latest
1 in 12 monthsEuropean Heart Journal
Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial
Randomised trial in 164 peopleInterventions